Activated suppressor cell function in multiple sclerosis — clinical correlations

Abstract

Activated suppressor cell function mediated by either freshly isolated peripheral blood mononuclear cells (MNCs), freshly isolated CD8 + lymphocytes or by CD8 + cell lines, has previously been found to be reduced compared to controls in multiple sclerosis (MS) patients with progressive disease (MS-P). In this study, we found that suppressor activity mediated by CD8 + cell lines, derived from MS patients with stable disease (MS-S) patients and maintained in culture for 14 days, was significantly greater (45 ± 6%) compared to that mediated by MS-P patients' CD8 + cells (11 ± 4%, P < 0.005). The MS-S suppressor values were, however, suggestively reduced compared to controls (60 ± 6%, P < 0.05). MNC-mediated suppressor values for the MS-S group (61 ± 5%) did not differ from the control group (67 ± 6%). Values for the MS-P group (7 ± 6%) were significantly reduced compared to MS-S and control groups. Cytotoxic activity mediated by CD8 + cell lines showing defective suppressor function did not differ from control values. The cell lines in MS and control did not differ with respect to their rate of proliferation in the presence of IL-2 and OKT3. Suppressor function in this assay was ablated if exogenous IL-2 was removed from the culture media. These data suggest that defective activated suppressor function is characteristic of the progressive form of MS, although a suppressor defect is also partially expressed in stable MS patients when CD8 + cell lines are studied.